Family Medicine Doctors in Imperial Beach, CA Accepting Medicare

9 Family Medicine doctors found. Showing 1 - 9

Dr. Daniel Johnson, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 949 Palm Ave, Imperial Beach, CA 91932 Phone: 619-429-3733    Fax: 619-429-6457

Faith Pauline Chisum, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 949 Palm Ave, Imperial Beach, CA 91932 Phone: 619-429-3733    Fax: 619-429-3823

Mr. Vernon Greg Phillips, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 707 Palm Ave, Imperial Beach, CA 91932 Phone: 619-429-7700    Fax: 619-429-7703

Danielle Richardson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 828 5th St, Imperial Beach, CA 91932 Phone: 913-710-2420

Parmela Sawhney, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 705 Palm Ave, Imperial Beach, CA 91932 Phone: 619-424-5106    Fax: 619-424-3648

Eric John Leute, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 949 Palm Avenue, Imperial Beach Health Center, Imperial Beach, CA 91932 Phone: 619-429-3733    Fax: 619-628-5550

Samantha Kasi Bodiford, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 949 Palm Ave, Imperial Beach, CA 91932 Phone: 619-429-3733

Mrs. Danielle Alexis Gordon, FNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 705 Palm Ave, Imperial Beach, CA 91932 Phone: 619-423-3774

Leonor A Ordonez, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 949 Palm Avenue, Imperial Beach Health Center, Imperial Beach, CA 91932 Phone: 619-429-3733    Fax: 619-429-6457

News Archive

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

Merck & Co., Inc., which operates in many countries as Merck Sharp & Dohme (MSD), has received a positive opinion from the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) for JANUVIA® tablets and JANUMET® tablets recommending their use as add-on to insulin for the treatment of type 2 diabetes.

The Partnership at Drugfree.org issues statement on FDA approval of VIVITROL for opioid dependence

The U.S. Food and Drug Administration's approval of Alkermes' opioid dependence medication (VIVITROL) for the prevention of relapse to opioid dependence following opioid detoxification is positive news for families of young adults and all those who are struggling to overcome opioid addiction. Addiction, a disease of the human brain, is a chronic illness while opioid dependence is frequently characterized by relapse.

Prevention and eradication of FVIII antibodies could improve hemophilia treatment

Octapharma AG is leading an international initiative focused on confronting the major risk associated with hemophilia A therapy - anti-factor VIII (FVIII) antibodies, also known as inhibitors. This initiative, combined with Octapharma's efforts to pursue the first recombinant FVIII therapy produced from a human cell line, could dramatically impact the treatment of an estimated one in every 5,000 to 10,000 men born with hemophilia A worldwide.

New law passed in Texas governing physician alternative practice sites will continue to help clinics to provide easy access to affordable health care

Legislation passed in Texas this year will, effective September 1, 2009, amend Texas law governing physician alternative practice sites, such as retail-based Convenient Care clinics. SB 532, supported by the Convenient Care Association and the Texas Medical Association, and sponsored by State Senator Dan Patrick (R-Houston) and Representative Garnet Coleman (D-Houston), increases Texans' access to affordable health care while ensuring high standards for quality of care.

Read more Medical News

› Verified 9 days ago